CompletedPhase 3

Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center

Egypt64 participantsStarted 2021-01-01

Plain-language summary

The goal of this clinical trial is to determine the most effective empirical therapy of antibiotics for better ventilator-associated pneumonia control. The main question it aims to answer is: • Which is better for clinical response single or combination empiric antibiotic therapies ?

Who can participate

Age range1 Month – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓Patients ranging from one month to twelve years old, who had been undergoing mechanical ventilation for over 48 hours and were diagnosed with Ventillator Associated Pneumonia.

What they're measuring

Antimicrobial susceptibility

Timeframe: 7 days

Trial details

NCT IDNCT06739382

SponsorBeni-Suef University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-01

View on ClinicalTrials.gov More Ventilation Acquired Pneumonia trials